Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin
2013; Wiley; Volume: 15; Issue: 7 Linguagem: Inglês
10.1111/dom.12076
ISSN1463-1326
AutoresChristoph Kapitza, Thomas Först, Hans Veit Coester, Franck Poitiers, Peter Ruus, Agnès Hincelin-Méry,
Tópico(s)Metabolism, Diabetes, and Cancer
ResumoAssess the pharmacodynamics of lixisenatide once daily (QD) versus liraglutide QD in type 2 diabetes insufficiently controlled on metformin.
Referência(s)